DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Saini SS, Bindslev-Jensen C, Maurer M. , et al.
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on h1 antihistamines: a randomized, placebo-controlled study.
J Invest Dermatol 2015;
135 (03) 925
Access:
We do not assume any responsibility for the contents of the web pages of other providers.